About   Help   FAQ
Apctm2.1Cip
Targeted Allele Detail
Summary
Symbol: Apctm2.1Cip
Name: APC, WNT signaling pathway regulator; targeted mutation 2, Christine Perret
MGI ID: MGI:3521822
Synonyms: Apc2lox14, Apcfle14, Apclox, Apctm2Cpe
Gene: Apc  Location: Chr18:34353977-34455605 bp, + strand  Genetic Position: Chr18, 18.53 cM
Alliance: Apctm2.1Cip page
Mutation
origin
Germline Transmission:  Earliest citation of germline transmission: J:94721
Parent Cell Line:  HM-1 (ES Cell)
Strain of Origin:  129P2/OlaHsd-Hprt1b-m3
Mutation
description
Allele Type:    Targeted (Conditional ready, No functional change)
Mutation:    Insertion
 
Mutation detailsA loxP site was inserted into intron 13 and a loxP flanked PGK-Hprt cassette into intron 14. Cre mediated recombination removed a floxed HPRT cassette that was inserted into exon 14, leaving exon 14 flanked with loxP sites. (J:94721)
Phenotypes
Key:
hm homozygous ht heterozygous tg involves transgenes phenotype observed
cn conditional genotype  cx complex: > 1 genome feature ot other: hemizygous, indeterminate,... N normal phenotype
Genotype/
Background:
Allelic Composition
Genetic Background
Cell Line(s)
Allelic CompositionGenetic BackgroundCell Line(s)
cn1  Disease Model
involves: 129P2/OlaHsd * C57BL/6N
 
 
 
involves: 129 * 129P2/OlaHsd * C57BL/6
 
involves: 129P2/OlaHsd * 129S4/SvJae * FVB
 
involves: 129P2/OlaHsd * C57BL/6
 
involves: 129P2/OlaHsd * C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj * DBA/2
 
involves: 129P2/OlaHsd * C57BL/6 * DBA/2
 
cn9  Disease Model
involves: 129P2/OlaHsd * C57BL/6 * DBA/2
 
involves: 129P2/OlaHsd * C57BL/6 * DBA/2
 
involves: 129P2/OlaHsd * FVB/N
 
Phenotypes:
Affected Systems
show or hide all annotated terms
                     
cellular
abnormal intestinal goblet cell morphology
abnormal autophagy
increased hepatocyte apoptosis
increased small intestinal crypt cell apoptosis
digestive/alimentary system
abnormal intestinal goblet cell morphology
abnormal intestine development
abnormal intestinal epithelium morphology
abnormal small intestine crypts of Lieberkuhn morphology
abnormal Paneth cell morphology
abnormal colon morphology
rectal prolapse
decreased intestinal adenoma incidence
increased intestinal adenocarcinoma incidence
increased intestinal adenoma incidence
increased colon adenoma incidence
intestine polyps
abnormal gut flora balance
abnormal intestine physiology
increased small intestinal crypt cell apoptosis
endocrine/exocrine glands
abnormal small intestine crypts of Lieberkuhn morphology
abnormal Paneth cell morphology
growth/size/body
cachexia
enlarged liver
liver hyperplasia
hematopoietic system
increased CD103-positive CD11b-low dendritic cell number
increased CD8-positive, alpha-beta T cell number
decreased NK T cell number
increased NK T cell number
increased regulatory T cell number
abnormal neutrophil physiology
abnormal NK T cell physiology
homeostasis/metabolism
abnormal autophagy
abnormal circulating enzyme level
abnormal chemokine level
immune system
increased CD103-positive CD11b-low dendritic cell number
increased CD8-positive, alpha-beta T cell number
decreased NK T cell number
increased NK T cell number
increased regulatory T cell number
abnormal immune system physiology
abnormal neutrophil physiology
abnormal NK T cell physiology
abnormal chemokine level
decreased interferon-gamma secretion
increased interferon-gamma secretion
increased interleukin-1 beta secretion
increased interleukin-10 secretion
increased interleukin-4 secretion
liver inflammation
liver/biliary system
increased hepatocyte apoptosis
liver inflammation
abnormal liver morphology
enlarged liver
liver hyperplasia
hepatic necrosis
increased hepatocellular carcinoma incidence
mortality/aging
premature death
decreased tumor-free survival time
neoplasm
N
neoplasm
N
decreased intestinal adenoma incidence
increased intestinal adenocarcinoma incidence
increased intestinal adenoma incidence
increased colon adenoma incidence
increased hepatocellular carcinoma incidence
View phenotypes and curated references for all genotypes (concatenated display).
Disease models
Key:
disease model   expected model not found
Models:
Human Diseases
cn1
cn9
IDs
IDs
Expression
In Mice Carrying this Mutation: 1 RNA-Seq or microarray experiment(s)
In Structures Affected by this Mutation: 7 anatomical structure(s)
Tumor Data
List all tumor models in MMHCdb carrying Apctm2.1Cip
Find Mice (IMSR)
Mouse strains and cell lines available from the International Mouse Strain Resource (IMSR)
Carrying this Mutation:  Mouse Strains: 2 strains available      Cell Lines: 0 lines available
Carrying any Apc Mutation:  157 strains or lines available
References
Original:  J:94721 Colnot S, et al., Liver-targeted disruption of Apc in mice activates beta-catenin signaling and leads to hepatocellular carcinomas. Proc Natl Acad Sci U S A. 2004 Dec 7;101(49):17216-21
All:  37 reference(s)

Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
12/10/2024
MGI 6.24
The Jackson Laboratory